Archive: July 2016

Bruton’s Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia and Lymphoma

Clinical Advances in Hematology & Oncology Volume 14, Issue 7, July 2016 Gaurav Varma, MSPH, Tyler P. Johnson, MD, and Ranjana H. Advani, MD Mr Varma […]

Long-term Outcomes of Neoadjuvant Treatment of HER2-Positive Breast Cancer

Bingnan Zhang, MD, MBA, and Sara Hurvitz, MD

Abstract: Long-term outcomes for women with a diagnosis of human epidermal growth factor receptor 2 (HER2)–driven early-stage breast cancer have significantly improved since the advent of […]

The Role of Microsatellite Instability Testing in Management of Colorectal Cancer

Frank A. Sinicrope, MD

H&O What is microsatellite instability (MSI)? FS MSI refers to an accumulation of errors within microsatellite regions of DNA that lead to hypermutation and are caused […]

Management of Invasive Aspergillosis in Acute Myelogenous Leukemia

Clinical Advances in Hematology & Oncology Volume 14, Issue 7, July 2016 Bruno C. Medeiros, MD Associate Professor of Medicine (Hematology) Stanford University School of Medicine […]

Current Insights Into the Impact of Dihydropyrimidine Dehydrogenase Deficiency in Patients Receiving Treatment With 5-Fluorouracil

Clinical Advances in Hematology & Oncology Volume 14, Issue 7, July 2016 Robert B. Diasio, MD William J. and Charles H. Mayo Professor Director, Mayo Clinic […]

Update on the Biology and Management of Neuroendocrine Prostate Cancer

Himisha Beltran, MD

H&O What is the definition of neuroendocrine prostate cancer (NEPC)? HB NEPC is an aggressive variant of prostate cancer that typically is diagnosed in the later stages […]

The Mediterranean Diet in Hypercoagulable States and Cancer

Miguel Ángel Martínez-González, MD, PhD, MPH

H&O What are the characteristics of the Mediterranean diet? MM The traditional Mediterranean diet refers to the dietary pattern that was typical until the mid-1960s of […]

Highlights in Breast Cancer From the 2016 American Society of Clinical Oncology Annual Meeting, June 3-7, 2016, Chicago, Illinois

Clinical Advances in Hematology & Oncology Volume 14, Issue 7, July 2016 Commentary by Hope S. Rugo, MD Abemaciclib Shows Signs of Efficacy and Tolerability in […]

Letter From the Editor: When Will We Ever Learn?

Clinical Advances in Hematology & Oncology Volume 14, Issue 7, July 2016 Bruce D. Cheson, MD This morning was one of the most beautiful of the […]

Back to Archive